Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT04724499

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy

Led by Dana-Farber Cancer Institute · Updated on 2026-01-22

30

Participants Needed

1

Research Sites

298 weeks

Total Duration

On this page

Sponsors

D

Dana-Farber Cancer Institute

Lead Sponsor

A

American Institute for Cancer Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this research is to determine whether a 16-week high intensity interval training (HIIT) exercise program will improve brain health among women undergoing chemotherapy and also improve cardiovascular (heart) function. The names of the study interventions involved in this study are/is: * High-Intensity Interval Training (HIIT)

CONDITIONS

Official Title

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women newly diagnosed with Stage I-III breast cancer
  • Age 18 years or older
  • Willing and able to provide written informed consent
  • Receiving neoadjuvant or adjuvant chemotherapy
  • Speak English
  • Able to obtain physician clearance to participate in exercise
  • Able to start a supervised exercise program without cardiovascular, respiratory, musculoskeletal, or joint problems that limit moderate activity
  • Have not lost 10% or more of body weight in the past 6 months
  • Currently do less than 60 minutes of structured exercise per week
  • Do not smoke and have not smoked in the past 12 months
  • Willing to travel to Dana-Farber Cancer Institute for assessments
  • Women of child-bearing potential must agree to pregnancy testing and use adequate contraception during the study and for 6 months after
Not Eligible

You will not qualify if you...

  • Uncontrolled illnesses such as active infection, uncontrolled diabetes, hypertension, or thyroid disease
  • Other active cancers
  • Metastatic breast cancer
  • History of coronary heart or artery disease, congestive heart failure, or heart insufficiency
  • Participate in more than 60 minutes of structured exercise per week
  • Orthopedic or other restrictions preventing high-intensity cycling exercise
  • Have a pacemaker or implantable device that is not safe for MRI
  • Unable to travel to Dana-Farber Cancer Institute
  • Pregnant women
  • Claustrophobia
  • Unable to comply with safety monitoring requirements as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

C

Christina Dieli-Conwright, MD

CONTACT

M

Mary Norris, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here